Global minimally invasive surgical devices market stood at USD20931.40 million in 2020 and is expected to grow at a CAGR of 5.56% during the forecast period on account of factors like increasing instances of chronic diseases and surgical interventions as their treatment. Rapidly growing demand for the advanced medical approach towards disease treatment and increased technological advancement in the medical devices are further driving the growth of the global minimally invasive surgical devices market in the upcoming five years.
Minimally invasive surgical devices are the medical devices that are utilized to carry out the surgeries without making major incisions or cuts on the body parts. The surgeries are performed either without incision or through minor cuts that limits the post-op wounds and decreases any severe blood loss instances. The process also minimizes the infections caused to the patient during or after surgery and supports faster healing of the patient.
Advantages of Minimally Invasive Surgical Devices
Utilization of minimally invasive surgical devices ensures added advantages during surgeries like high precision and accuracy, higher control, and enhanced vision to the surgeon during the surgical procedures. These added advantages positively influence the growth of the global minimally invasive surgical devices market in the upcoming five years. Also, these procedures are less traumatic and has faster healing thus influencing patient’s preference toward the surgery and further supporting the growth of the global minimally invasive surgical devices market in the next five years.
According to the United Nations Department of Economic and Social Affairs, Population Division, the number of people aged 65 years or above was 702.9 million in 2019. This number is expected to grow by 120% and reach 1548.9 million by 2050.
Growing Prevalence of Chronic Diseases
The growing prevalence of chronic diseases such as cancer, cardiovascular diseases, gastrointestinal disorders, renal disorders, and urological problems has significantly increased the volume of surgical procedures being performed, thereby driving the growth of global minimally invasive surgical devices market.
The total number of new deaths across all gender and age groups accounted to be around 9,958,133. The most observed cancer types in 2020 were breast cancer, lung cancer, colorectum cancer, prostate cancer and stomach cancer. All these numbers are expected to increase significantly in the coming years, thereby driving the market growth.
Rise in Caseload of Neurological Disorders
The growing prevalence of various neurological disorders, including stroke, headache disorders, epilepsy, cerebral palsy, among others, coupled with an increase in injury related neurological disorders such as traumatic brain injuries and spinal cord injuries has significantly increased the volume of minimally invasive neurological surgeries being performed, thereby supporting the growth of minimally invasive surgical devices market.
Market Segmentation
Company Profile
Medtronic Plc, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings, Inc, Johnson & Johnson, Karl Storz SE & Co. KG, Abbott Laboratories, Inc., Koninklijke Philips N.V., Applied Medical Resources Corporation, Conmed Corporation, The Cooper Companies Inc., Biolitec AG, FUJIFILM Holdings Corporation, Smith & Nephew plc, are some of the major players operating in the global minimally invasive surgical devices market.
Attribute | Details |
Market size value in 2020 | USD20931.40 Million |
Revenue Forecast in 2026 | USD28540.08 Million |
United States Market size value in 2020 | USD4530.07 Million |
Growth Rate | 5.56% |
Base Year | 2020 |
Historical Years | 2016 – 2019 |
Estimated Year | 2021 |
Forecast Period | 2022 – 2026 |
Quantitative Units | Revenue in USD Million, and CAGR for 2016-2020 and 2021-2026 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | - Material
- Form
- Procedure
- End User
|
Regional Scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country Scope | United States; Canada; Mexico; Germany; Italy; United Kingdom; France; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; |
Key Companies Profiled | Medtronic Plc, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings, Inc, Johnson & Johnson, Karl Storz SE & Co. KG, Abbott Laboratories, Inc., Koninklijke Philips N.V., Applied Medical Resources Corporation, Conmed Corporation, The Cooper Companies Inc., Biolitec AG, FUJIFILM Holdings Corporation, Smith & Nephew plc |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request) |